Literature DB >> 16123500

Female advantage in AMI mortality is reversed in patients with type 2 diabetes in the Skaraborg Project.

Charlotte A Larsson1, Bo Gullberg, Juan Merlo, Lennart Rastam, Ulf Lindblad.   

Abstract

Entities:  

Mesh：

Year:  2005        PMID： 16123500     DOI： 10.2337/diacare.28.9.2246

Source DB:  PubMed          Journal:  Diabetes Care        ISSN： 0149-5992            Impact factor:   19.112


× No keyword cloud information.
  7 in total

1.  Cholesterol in women at high cardiovascular risk is less successfully treated than in corresponding men. The Skaraborg Hypertension and Diabetes Project.

Authors:  Anita Mehner; Ulf Lindblad; Lennart Råstam; Kristina Bengtsson Boström
Journal:  Eur J Clin Pharmacol       Date:  2008-04-04       Impact factor: 2.953

2.  Predictors of acute myocardial infarction mortality in hypertensive patients treated in primary care: a population-based follow-up study in the Skaraborg Project.

Authors:  Erik Bøg-Hansen; Charlotte A Larsson; Bo Gullberg; Arne Melander; Kristina Boström; Lennart Råstam; Ulf Lindblad
Journal:  Scand J Prim Health Care       Date:  2007-12       Impact factor: 2.581

3.  Gender differences in composite control of cardiovascular risk factors among patients with type 2 diabetes.

Authors:  Joni L Strom Williams; Cheryl P Lynch; Rhonda Winchester; Leslie Thomas; Brad Keith; Leonard E Egede
Journal:  Diabetes Technol Ther       Date:  2014-04-15       Impact factor: 6.118

4.  A variation in the cerebroside sulfotransferase gene is linked to exercise-modified insulin resistance and to type 2 diabetes.

Authors:  A Roeske-Nielsen; K Buschard; J E Månson; L Rastam; U Lindblad
Journal:  Exp Diabetes Res       Date:  2009-07-05

5.  Relationship between insulin resistance and coronary artery calcium in young men and women.

Authors:  Ki-Chul Sung; Jin-Ho Choi; Hyeon-Cheol Gwon; Seung-Hyuk Choi; Bum-Soo Kim; Hyon Joo Kwag; Sun H Kim
Journal:  PLoS One       Date:  2013-01-16       Impact factor: 3.240

6.  The Asp298 allele of endothelial nitric oxide synthase is a risk factor for myocardial infarction among patients with type 2 diabetes mellitus.

Authors:  Jacob Odeberg; Charlotte A Larsson; Lennart Råstam; Ulf Lindblad
Journal:  BMC Cardiovasc Disord       Date:  2008-12-10       Impact factor: 2.298

7.  ST-segment elevation myocardial infarction in women with type 2 diabetes.

Authors:  Edyta Radomska; Marcin Sadowski; Jacek Kurzawski; Marek Gierlotka; Lech Polonski
Journal:  Diabetes Care       Date:  2013-10-02       Impact factor: 19.112
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.